9/18/2025CTTQ Launches Phase 3 Trial for TQB2868 in Metastatic Pancreatic Cance...

9/18/2025Starry Gene Secures ¥100M+ in Series A2 Funding to Advance Gene Thera...

9/18/2025NiKang Thera Completes Dosing of the First Cohort in a Phase 1 Study o...

9/17/2025U.S. Senate Warns of National Security Risks from Chinese Pharmaceutic...

9/17/2025ALK-Abelló Partners with GenSci to Expand Allergy Immunotherapy Marke...

9/17/2025CDE Invites Public Comment on Draft Guidelines for CAR-T Cell Therapy ...

9/17/2025CDE Solicits Opinions on Draft Q&A for Development Safety Update Repor...

9/17/2025CDE Seeks Feedback on Reference Formulations for Chemical Generic Drug...

9/17/2025Chigenovo Secures Series B+ Funding to Advance Gene Therapy

9/17/2025AnDiConBio Secures Series A+ Funding

9/17/2025OllinBio Launches with $100M to Develop Innovative Ophthalmic Therapie...

More>>

9/18/2025On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (C...

9/18/2025Strengthening Oversight of Imported Drugs: Key Takeaways into New Regu...

9/15/2025Merger Control in China's Healthcare Industry: Insights into Antitrust...

9/13/2025NHSA Issues the Regulations on DRG/DIP Healthcare Security Payment Mec...

9/12/2025The Rise of US-China Biotech Partnerships: Opportunities and Emerging ...

9/10/2025U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on Chi...

9/5/2025How China Seeks to Solve Its Quality Control Conundrum (C&EN)

9/3/2025China Biopharma Tracker – August 2025 (PharmaDJ)

9/3/2025China's Biopharma Industry Clusters: Mapping Opportunities and Regiona...

9/2/2025China's Clinical Trial Quality Management Faces Key Challenges Despite...

8/27/2025AstraZeneca Bounces Back from Scandal in China with $2.5B R&D Push

More>>